Resmed (RSMDF) Capital Expenditures Growth (1y) (2010 - 2026)
Powered by 
Analysis
Resmed (RSMDF) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn | -1.00% |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | -27.50% |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn | -0.20% |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn | 10.38% |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn | 24.20% |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | 35.70% |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn | 5.88% |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn | -9.99% |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | -6.52% |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 67.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67.16% |
| Mar 31, 2026 | 61.83% |
| Dec 31, 2025 | 38.24% |
| Sep 30, 2025 | 140.84% |
| Jun 30, 2025 | 22.93% |
| Mar 31, 2025 | -1.86% |
| Dec 31, 2024 | -11.60% |
| Sep 30, 2024 | -40.60% |
| Jun 30, 2024 | -27.77% |
| Mar 31, 2024 | -26.46% |
| Dec 31, 2023 | -14.61% |
| Sep 30, 2023 | 3.37% |
| Jun 30, 2023 | 20.27% |
| Mar 31, 2023 | -40.52% |
| Dec 31, 2022 | -10.05% |
| Sep 30, 2022 | 6.28% |
| Jun 30, 2022 | 2.64% |
| Mar 31, 2022 | 83.77% |
| Dec 31, 2021 | -12.98% |
| Sep 30, 2021 | 102.50% |